Persistence Market Research Pvt. Ltd is released new forthcoming report on title "Statins Market: Global Industry Analysis and Forecast to 2020".
New York, NY -- (SBWIRE) -- 06/08/2015 -- Overall pharmaceutical market is growing at a high rate globally. However, some of its segments such as dyslipidemia therapeutics market are expected to experience significant decline due to expiries of various patented drugs and introduction of generic drugs in the market. Statins refers to a class of drugs that are used to lower cholesterol levels in the body. They work on the principle of inhibiting the enzyme HMG-CoA reductase that plays a vital role in the production of cholesterol in the body. Proper regulation of cholesterol levels is important, as increased cholesterol levels lead to cardiovascular diseases. Statins help in maintaining cholesterols levels at appropriate levels in body.
Buy Full Report: http://www.persistencemarketresearch.com/market-research/statins-market.asp
North America dominates the global market for statins due to aging population and increasing prevalence for high cholesterol cases in the region. Globally, the statins market is expected to experience significant loss, due to the introduction of generic statins in market. Some of the key driving forces for statins market in emerging countries are large pool of patients and rising standards of healthcare in these areas.
Guidelines from various institutions such as European Society of Cardiology (ESC) and European Atherosclerosis Society (EAS) as well as programs such as The National Cholesterol Education Program (NECP) have recommended the use of statins for treatment of high cholesterol levels. These factors are expected to drive the global statins market. However, due to fewer products available in statins category and their patent expiries, the global statins market is expected to experience significant loss in near future. In addition, high cost involved, shortage of novel molecules in R&D for products and increasing availability of generics is expected to restrain the global statins market.
Leading companies are involved in R&D for novel molecules. Innovation of some molecule is expected to offer new opportunity for statins market. Major trends that have been observed in the market include shift of focus from the use of statins drugs towards non-statins and combination therapies. In addition, many new players have evolved for production of its generic drugs. Some of the major companies dealing in the global statins market include Pfizer Inc., AstraZeneca PLC, Merck & Co Inc and Novartis AG.
Request Full TOC: http://www.persistencemarketresearch.com/toc/3038
Key points covered in the report
1) Report segments the market on the basis of types, application, products, technology, etc (as applicable)
2) The report covers geographic segmentation
3) The report provides the market size and forecast for the different segments and geographies for the period of 2010 to 2020
4) The report provides company profiles of some of the leading companies operating in the market
5) The report also provides porters five forces analysis of the market.-
About Persistence Market Research
Persistence Market Research (PMR) is a U.S.-based full-service market intelligence firm specializing in syndicated research, custom research, and consulting services. PMR boasts market research expertise across the Healthcare, Chemicals and Materials, Technology and Media, Energy and Mining, Food and Beverages, Semiconductor and Electronics, Consumer Goods, and Shipping and Transportation industries. The company draws from its multi-disciplinary capabilities and high-pedigree team of analysts to share data that precisely corresponds to clients' business needs.
PMR stands committed to bringing more accuracy and speed to clients' business decisions. From ready-to-purchase market research reports to customized research solutions, PMR's engagement models are highly flexible without compromising on its deep-seated research values.